MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma.
about
Prognostic significance of microRNA-101 in solid tumor: A meta-analysis.The prognostic value of decreased miR-101 in various cancers: a meta-analysis of 12 studies.Glioblastoma research: US and international networking achievements.Long noncoding RNA MALAT1 knockdown reverses chemoresistance to temozolomide via promoting microRNA-101 in glioblastoma.Potential Strategies Overcoming the Temozolomide Resistance for GlioblastomaGlioblastoma Chemoresistance: The Double Play by Microenvironment and Blood-Brain Barrier
P2860
MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma.
@en
MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma.
@nl
type
label
MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma.
@en
MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma.
@nl
prefLabel
MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma.
@en
MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma.
@nl
P2093
P2860
P356
P1433
P1476
MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma.
@en
P2093
P2860
P304
79584-79595
P356
10.18632/ONCOTARGET.12861
P407
P577
2016-10-25T00:00:00Z